| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |